Lymphoma

Showing NaN - NaN of 79

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

Lymphoma Trial in Australia, United States (RP4010)

Terminated
  • Lymphoma
  • Birmingham, Alabama
  • +10 more
Dec 26, 2019

Lymphoma Trial in Worldwide (asparaginase, cyclophosphamide, cytarabine)

Completed
  • Lymphoma
  • Birmingham, Alabama
  • +175 more
Jul 24, 2019

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Detroit (biological, drug, other, procedure)

Terminated
  • Chronic Myeloproliferative Disorders
  • +7 more
  • anti-thymocyte globulin
  • +7 more
  • Detroit, Michigan
    Karmanos Cancer Institute
Mar 13, 2019

Leukemia, Lymphoma, Blood Disorders Trial in Detroit (Ethanol lock therapy (ELT))

Completed
  • Leukemia
  • +3 more
  • Ethanol lock therapy (ELT)
  • Detroit, Michigan
    Children's Hospital of Michigan
Dec 1, 2018

Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer Trial in Worldwide (denosumab)

Completed
  • Breast Cancer
  • +15 more
  • Encinitas, California
  • +23 more
Sep 20, 2018

Lymphoma Trial in Worldwide (PCI-32765 (Ibrutinib))

Completed
  • Lymphoma
  • PCI-32765 (Ibrutinib)
  • Los Angeles, California
  • +53 more
Jul 14, 2017

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Detroit (biological, drug, radiation)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • rituximab
  • +9 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
May 26, 2017

Chemotherapy or Malignancy-Induced Hyperuricemia in

Completed
  • Leukemia
  • +3 more
  • Palo Alto, California
  • +10 more
Apr 24, 2017

Lymphoma Trial in United States (biological, drug, radiation)

Completed
  • Lymphoma
  • rituximab
  • +5 more
  • Mobile, Alabama
  • +91 more
Jan 12, 2017

Cachexia, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (Juven, Non-Juven Supplement)

Completed
  • Cachexia
  • +3 more
  • Juven
  • Non-Juven Supplement
  • Birmingham, Alabama
  • +249 more
Dec 6, 2016

Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Detroit (Aprepitant, Cyclophosphamide, Dexamethasone)

Completed
  • Breast Cancer
  • +11 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Feb 12, 2016

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Detroit (drug, procedure, radiation)

No longer available
  • Leukemia
  • +5 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Feb 26, 2016

Leukemia, Lymphoma Trial in Australia, Canada, United States (arsenic trioxide)

Completed
  • Leukemia
  • Lymphoma
  • arsenic trioxide
  • Little Rock, Arkansas
  • +51 more
Apr 28, 2015

Lymphoma Trial in Detroit (biological, drug, procedure)

Completed
  • Lymphoma
  • therapeutic autologous lymphocytes
  • +5 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 25, 2015

Lymphoma Trial in United States (biological, drug, procedure)

Withdrawn
  • Lymphoma
  • rituximab
  • +12 more
  • Hartford, Connecticut
  • +28 more
Mar 5, 2015

Lymphoma Trial in United States (biological, drug, procedure)

Completed
  • Lymphoma
  • filgrastim
  • +4 more
  • Mobile, Alabama
  • +83 more
Mar 5, 2015

Lymphoma Trial in United States (cisplatin, etoposide, gemcitabine)

Completed
  • Lymphoma
  • Tucson, Arizona
  • +76 more
Sep 18, 2014

Lymphoma Trial in Worldwide (doxorubicin HCl, mercaptopurine, methotrexate)

Completed
  • Lymphoma
  • doxorubicin hydrochloride
  • +5 more
  • Birmingham, Alabama
  • +158 more
Sep 10, 2014

Lymphoma Trial in Worldwide (carmustine, cyclophosphamide, etoposide)

Completed
  • Lymphoma
  • Birmingham, Alabama
  • +234 more
Jul 31, 2014

Cardiac Toxicity, Lymphoma Trial in Canada, Switzerland, United States (biological, drug, radiation)

Completed
  • Cardiac Toxicity
  • Lymphoma
  • bleomycin sulfate
  • +8 more
  • Birmingham, Alabama
  • +62 more
Jul 23, 2014

Lymphoma Trial in Detroit (bryostatin 1)

Completed
  • Lymphoma
  • bryostatin 1
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 9, 2014

Development of Strategies to Increase Enrollment in Clinical

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • psychosocial assessment and care
  • Sacramento, California
  • +30 more
Feb 12, 2014